Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05757> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05757 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05757 label "DNB-001 [drugbank:DB05757]" assertion.
- drugbank:DB05757 seeAlso DB05757 assertion.
- drugbank:DB05757 description "DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma. In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve." assertion.
- drugbank:DB05757 identifier "drugbank:DB05757" assertion.
- drugbank:DB05757 title "DNB-001" assertion.
- drugbank:DB05757 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05757 drugbank_vocabulary:drugbank-id "DB05757" assertion.
- drugbank:DB05757 bio2rdf_vocabulary:x-identifiers.org DB05757 assertion.
- drugbank:DB05757 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05757" assertion.
- drugbank:DB05757 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05757 bio2rdf_vocabulary:identifier "DB05757" assertion.